AZN logo

AstraZeneca PLC (AZN) return on equity

annual ROE:

17.60%+1.96%(+12.53%)
December 31, 2024

Summary

  • As of today (August 21, 2025), AZN annual return on equity is 17.60%, with the most recent change of +1.96% (+12.53%) on December 31, 2024.
  • During the last 3 years, AZN annual ROE has risen by +17.18% (+4090.48%).
  • AZN annual ROE is now -78.07% below its all-time high of 80.26%, reached on December 31, 1991.

Performance

AZN ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNprofitability metrics

quarterly ROE:

20.07%+0.64%(+3.29%)
June 30, 2025

Summary

  • As of today (August 21, 2025), AZN quarterly return on equity is 20.07%, with the most recent change of +0.64% (+3.29%) on June 30, 2025.
  • Over the past year, AZN quarterly ROE has increased by +3.19% (+18.90%).
  • AZN quarterly ROE is now -65.42% below its all-time high of 58.04%, reached on December 31, 1998.

Performance

AZN quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AZN ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.5%+18.9%
3 y3 years+4090.5%+636.6%
5 y5 years+105.4%+35.9%

AZN ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+4090.5%at high+636.6%
5 y5-year-15.4%+4090.5%-29.4%+636.6%
alltimeall time-78.1%+4090.5%-65.4%+636.6%

AZN ROE History

DateAnnualQuarterly
Jun 2025
-
20.07%(+3.3%)
Mar 2025
-
19.43%(+9.5%)
Dec 2024
17.60%(+12.5%)
17.75%(+6.1%)
Sep 2024
-
16.73%(-0.9%)
Jun 2024
-
16.88%(-0.3%)
Mar 2024
-
16.93%(+6.0%)
Dec 2023
15.64%(+81.2%)
15.97%(-1.2%)
Sep 2023
-
16.16%(-4.9%)
Jun 2023
-
17.00%(+30.3%)
Mar 2023
-
13.05%(+45.8%)
Dec 2022
8.63%(+1954.8%)
8.95%(+63.3%)
Sep 2022
-
5.48%(-246.5%)
Jun 2022
-
-3.74%(+3.0%)
Mar 2022
-
-3.63%(-889.1%)
Dec 2021
0.42%(-98.0%)
0.46%(-93.8%)
Sep 2021
-
7.38%(-71.4%)
Jun 2021
-
25.79%(-9.3%)
Mar 2021
-
28.43%(+26.1%)
Dec 2020
20.80%(+142.7%)
22.55%(+26.5%)
Sep 2020
-
17.83%(+20.7%)
Jun 2020
-
14.77%(+41.2%)
Mar 2020
-
10.46%(+18.3%)
Dec 2019
8.57%(-35.9%)
8.84%(-38.3%)
Sep 2019
-
14.33%(-5.2%)
Jun 2019
-
15.12%(-9.9%)
Mar 2019
-
16.78%(+19.6%)
Dec 2018
13.36%(-22.4%)
14.03%(-9.2%)
Sep 2018
-
15.46%(-7.3%)
Jun 2018
-
16.67%(-4.1%)
Mar 2018
-
17.38%(-4.3%)
Dec 2017
17.22%(-11.1%)
18.16%(-18.1%)
Sep 2017
-
22.17%(-9.3%)
Jun 2017
-
24.43%(+16.3%)
Mar 2017
-
21.00%(+1.3%)
Dec 2016
19.36%(+30.7%)
20.74%(+43.3%)
Sep 2016
-
14.47%(+14.8%)
Jun 2016
-
12.60%(-23.7%)
Mar 2016
-
16.51%(+6.0%)
Dec 2015
14.81%(+157.1%)
15.57%(+70.2%)
Sep 2015
-
9.15%(+51.0%)
Jun 2015
-
6.06%(-4.9%)
Mar 2015
-
6.37%(+10.2%)
Dec 2014
5.76%(-46.9%)
5.78%(+25.4%)
Sep 2014
-
4.61%(-47.7%)
Jun 2014
-
8.81%(-0.5%)
Mar 2014
-
8.85%(-17.7%)
Dec 2013
10.84%(-58.9%)
10.75%(-45.7%)
Sep 2013
-
19.81%(-6.7%)
Jun 2013
-
21.23%(-15.2%)
Mar 2013
-
25.03%(-8.8%)
Dec 2012
26.36%(-37.8%)
27.45%(+1.4%)
Sep 2012
-
27.08%(-23.3%)
Jun 2012
-
35.32%(-6.4%)
Mar 2012
-
37.73%(-12.5%)
Dec 2011
42.41%(+16.7%)
43.11%(-3.0%)
Sep 2011
-
44.44%(+21.3%)
Jun 2011
-
36.65%(-0.5%)
Mar 2011
-
36.82%(+2.2%)
Dec 2010
36.35%(-10.6%)
36.04%(-3.2%)
Sep 2010
-
37.23%(-10.7%)
Jun 2010
-
41.67%(-2.8%)
Mar 2010
-
42.88%(+1.7%)
Dec 2009
40.67%
42.15%(+2.4%)
Sep 2009
-
41.15%(+2.5%)
Jun 2009
-
40.13%(-2.8%)
DateAnnualQuarterly
Mar 2009
-
41.27%(+9.9%)
Dec 2008
39.93%(+7.6%)
37.55%(-4.7%)
Sep 2008
-
39.40%(+3.8%)
Jun 2008
-
37.97%(+0.4%)
Mar 2008
-
37.82%(-0.4%)
Dec 2007
37.10%(-10.9%)
37.99%(-3.1%)
Sep 2007
-
39.21%(-3.6%)
Jun 2007
-
40.68%(-4.1%)
Mar 2007
-
42.42%(+1.9%)
Dec 2006
41.66%(+24.3%)
41.62%(+0.9%)
Sep 2006
-
41.26%(+5.7%)
Jun 2006
-
39.05%(+5.2%)
Mar 2006
-
37.13%(+8.8%)
Dec 2005
33.52%(+26.3%)
34.12%(+6.4%)
Sep 2005
-
32.08%(-0.1%)
Jun 2005
-
32.10%(+7.7%)
Mar 2005
-
29.81%(+4.7%)
Dec 2004
26.54%(+6.2%)
28.47%(+6.7%)
Sep 2004
-
26.69%(+9.5%)
Jun 2004
-
24.38%(+5.6%)
Mar 2004
-
23.09%(-5.5%)
Dec 2003
24.99%(-8.1%)
24.44%(+5.4%)
Sep 2003
-
23.19%(-1.4%)
Jun 2003
-
23.52%(-5.6%)
Mar 2003
-
24.91%(-4.7%)
Dec 2002
27.18%(-11.6%)
26.14%(-13.8%)
Sep 2002
-
30.32%(-4.8%)
Jun 2002
-
31.86%(-1.7%)
Mar 2002
-
32.40%(+5.9%)
Dec 2001
30.76%(+11.3%)
30.60%(+20.3%)
Sep 2001
-
25.43%(+5.2%)
Jun 2001
-
24.18%(-3.0%)
Mar 2001
-
24.92%(+3.9%)
Dec 2000
27.64%(+108.6%)
23.98%(+40.6%)
Sep 2000
-
17.06%(+11.0%)
Jun 2000
-
15.37%(+19.6%)
Mar 2000
-
12.85%(+9.3%)
Dec 1999
13.25%(-56.2%)
11.76%(-66.6%)
Sep 1999
-
35.20%(-12.3%)
Jun 1999
-
40.15%(+0.3%)
Mar 1999
-
40.02%(-31.0%)
Dec 1998
30.22%(-8.9%)
58.04%(+35.0%)
Sep 1998
-
42.99%(-11.4%)
Jun 1998
-
48.53%(+27.9%)
Mar 1998
-
37.95%(-10.0%)
Dec 1997
33.18%(+8.9%)
42.15%(-12.1%)
Sep 1997
-
47.95%(+3.7%)
Jun 1997
-
46.24%(+3.7%)
Mar 1997
-
44.59%(-11.4%)
Dec 1996
30.46%(+58.8%)
50.34%(+46.7%)
Sep 1996
-
34.31%(+11.6%)
Jun 1996
-
30.73%(+6.8%)
Mar 1996
-
28.77%(+1.6%)
Dec 1995
19.18%(-27.3%)
28.32%(-20.8%)
Sep 1995
-
35.76%(-6.5%)
Jun 1995
-
38.23%(-9.9%)
Mar 1995
-
42.44%(+7.3%)
Dec 1994
26.40%(-43.9%)
39.56%(+4.7%)
Sep 1994
-
37.78%(+4.7%)
Jun 1994
-
36.09%(+24.7%)
Mar 1994
-
28.94%(+0.7%)
Dec 1993
47.10%(+93.1%)
28.75%
Dec 1992
24.39%(-69.6%)
-
Dec 1991
80.26%(+10.2%)
-
Dec 1990
72.83%
-

FAQ

  • What is AstraZeneca PLC annual return on equity?
  • What is the all time high annual ROE for AstraZeneca PLC?
  • What is AstraZeneca PLC annual ROE year-on-year change?
  • What is AstraZeneca PLC quarterly return on equity?
  • What is the all time high quarterly ROE for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly ROE year-on-year change?

What is AstraZeneca PLC annual return on equity?

The current annual ROE of AZN is 17.60%

What is the all time high annual ROE for AstraZeneca PLC?

AstraZeneca PLC all-time high annual return on equity is 80.26%

What is AstraZeneca PLC annual ROE year-on-year change?

Over the past year, AZN annual return on equity has changed by +1.96% (+12.53%)

What is AstraZeneca PLC quarterly return on equity?

The current quarterly ROE of AZN is 20.07%

What is the all time high quarterly ROE for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly return on equity is 58.04%

What is AstraZeneca PLC quarterly ROE year-on-year change?

Over the past year, AZN quarterly return on equity has changed by +3.19% (+18.90%)
On this page